Interpace Diagnostics: High Margin Molecular Diagnostic Tests & Pathology Services

Jul. 25, 2017
Interpace Diagnostics (NASDAQ: IDXG) provides clinically useful molecular diagnostic tests and pathology services for evaluating the risk of cancer by ...

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market